Cilostazol
5 trials in this asset. Source: ClinicalTrials.gov, as of July 21, 2026.
Trials
5
Ongoing
0
Recruiting
0
Completed
4
Sites
7
Countries
4
Endpoints
42
Composite endpoints
0
Distinct sites and countries across this asset's trials. A site running several of its trials counts once, matching the map. All 42 linked ClinicalTrials.gov endpoints are classified into the categories below. Trial and endpoint linkage does not by itself establish treatment attribution for every endpoint.
Development
Where the program stands
Trials by phase
Trials by status
Evidence coverage
What this asset has been measured on
Endpoints grouped into outcome categories, ranked by how often they are measured across this asset's trials.
Most-measured metrics
Top 20 metrics across this asset's endpoints
Normalized metric codes are available for 13 of 42 classified ClinicalTrials.gov endpoints for this asset; the ranking below covers that coded subset.
5
3
3
2
Trials
Trials for this asset
Every trial for this asset, with the same search, filters, and sort as the Trials tab.
5 of 5
| Asset / Disease area | Key I/E criterion | Evidence | ||||||
|---|---|---|---|---|---|---|---|---|
| CAVADCilostazol Verse Asprin for Vascular Dementia in Poststroke Patients With White Matter Lesions | Aspirin, Cilostazol Vascular cognitive impairment / dementia, Mixed / unspecified dementia | Vascular or mixed dementia | Ph 4 | Completed | 2 | May 2011 | 1 | |
| Prevent-SVDLacunar Intervention Trial 1 (LACI-1) | Cilostazol, isosorbide mononitrate Mixed / unspecified dementia | Age ≥35 | Ph 2 | Completed | 2 | Aug 2017 | 1 | |
| NCT02491268A Trial of Cilostazol in Patients With Mild Cognitive Impairment (COMCID) | Cilostazol MCI / preclinical Alzheimer’s | Mild cognitive impairment | Ph 2 | Completed | 1 | Aug 2020 | 1 | |
| NCT01872858Efficacy and Safety of Cilostazol in Patients of Vascular Cognitive Impairment-no Dementia (VCIND) | Aspirin, Cilostazol Vascular cognitive impairment / dementia | Age 50-80 | Not applicable | Unknown | 1 | Nov 2012 | - | |
| NCT01409564Cilostazol Augmentation Study in Dementia | Cilostazol Alzheimer’s disease | Alzheimer's disease | Ph 4 | Completed | 1 | Jun 2012 | 1 | results |
Showing 1-5 of 5 trials